|
Mosapride
citrate API
|
|
|
|
Haorui supplies Mosapride citrate
API (Active Pharmaceutical Ingredients) to
pharmaceutical industry. Our bulk Mosapride
citrate actives is produced by GMP facility.
Welcome to contact us for
product detail.
|
|
|
|
The following information is
provided for general information purposes ONLY.
|
|
|
|
What is Mosapride?
|
|
Mosapride
is a new prokinetic agent widely used in Japan and is
structurally related to cisapride. However, it binds
exclusively to serotonin 5-HT4 receptors and has no
dopaminergic action.
|
|
Mosapride, a 5HT-4 receptor agonist, improves insulin sensitivity and
glycaemic control in patients with Type II diabetes
mellitus.
|
|
|
|
The history of Mosapride
|
|
Mosapride
is a substituted benzamide used for its prokinetic
properties.
|
|
|
|
What is Mosapride used for?
|
|
Mosapride
citrate is a new gastroprokinetic agent that enhances
the upper GI motility by stimulating 5-hydroxytryptamine4
(5-HT4) receptors.
|
|
Mosapride citrate, a
substituted benzamide, is a novel 5-HT4
receptor agonist. It has been reported that mosapride
increases the gastric emptying in rats,
stimulates the gastric motor activity in
conscious dogs and increases the electrically evoked
contractions in isolated guinea pig ileum
|
|
|
Mosapride
pharmacokinetics
|
|
CAS Type 1 Name:
Benzamide,
4-amino-5-chloro-2-ethoxy-N-((4-((4-fluorophenyl)methyl)-2-morpholinyl)methyl)-,2-hydroxy-1,2,3-propanetricarboxylate (1:1)
|
|
Chemical
Synonyms:
4-amino-5-chloro-2-ethoxy-N-((4-(4-fluorobenzyl)-2-morpholinyl)methyl)benzamide
AS 4370
AS-4370
|
|
Chemical
Drawing:
|
|
|
|
|
|
Disclaimer:
|
|
Information on
this page is provided for general information purposes.
You should not make a clinical treatment decision based
on information contained in this page without consulting
other references including the package insert of the
drug, textbooks and where relevant, expert opinion. We
cannot be held responsible for any errors you make in
administering drugs mentioned on this page, nor for use
of any erroneous information contained on this page.
|
